Rationale Endocannabinoids (eCBs) are critical gatekeepers of dopaminergic signaling, and disrupting cannabinoid receptor-1 (CB1) signaling alters DA dynamics to attenuate cue-motivated behaviors. Prior studies suggest that dopamine (DA) release plays a critical role in driving sign-tracking. Objectives Here, we determine whether systemic injections of rimonabant, a CB1 receptor inverse agonist, during Pavlovian lever autoshaping impair the expression of sign-tracking. We next examine whether rimonabant blocks the reinforcing properties of the Pavlovian lever cue in a conditioned reinforcement test. Methods In Exp. 1, we trained rats in Pavlovian lever autoshaping prior to systemic rimonabant injections (0, 1, 3 mg/kg) during early and late Pavlovian lever autoshaping sessions. In Exp. 2, we trained rats in Pavlovian lever autoshaping prior to systemic rimonabant injections (0, 1 mg/kg) during a conditioned reinforcement test. Results Rimonabant dose-dependently decreased lever contact and probability, and increased sign-tracker's latency to approach the lever cue early in Pavlovian training. With extended training, many previously goal-tracking and intermediate rats shifted to lever approach, which remained dose-dependently sensitive to rimonabant. Rimonabant attenuated cue-evoked food cup approach early, but not late, in conditioning, and did not affect pellet retrieval or consumption. The inserted lever cue served as a robust conditioned reinforcer after Pavlovian lever autoshaping, and 1 mg/kg rimonabant blocked conditioned reinforcement. Conclusions Together, our results suggest that CB1 signaling mediates two critical properties of incentive stimuli; their ability to attract (Exp. 1) and their ability to reinforce (Exp. 2) behavior.
Introduction
Endocannabinoids (eCBs) are critical gatekeepers of the dopamine (DA) system and influence cue-motivated behaviors (Lupica and Riegel 2005; Cheer et al. 2007; Solinas et al. 2008; Hernandez and Cheer 2012; Oleson et al. 2012) . Disrupting cannabinoid receptor-1 (CB1) signaling attenuates cue-evoked accumbal DA release and interferes with cuemotivated behaviors (Oleson et al. 2012) . Cue-evoked dopamine release in the accumbens is a neurobiological signature of sign-tracking, but not goal-tracking (Flagel et al. 2011) . Sign-tracking and goal-tracking are behaviors that emerge during a Pavlovian lever autoshaping (PLA) paradigm. Signtracking rats interact with an inserted lever cue that predicts reward, while goal-trackers interact with the food cup where Sam Z. Bacharach and Helen M. Nasser contributed equally to this work.
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food is delivered (Hearst and Jenkins 1974; Boakes 1977; Flagel et al. 2007 ). Sign-tracking to lever cues has been posited to reflect an incentive motivational process in which the appetitive motivational properties of the reward are transferred to the conditioned lever cue, such that the lever cue attracts, invigorates, and reinforces behavior (Tomie 1996; Flagel et al. 2009; Robinson and Flagel 2009; Beckmann and Chow 2015) . While DA plays a role in driving approach behaviors of both sign-and goal-trackers (Lopez et al. 2015; Fraser et al. 2016) , DA action in the nucleus accumbens (NAc) mediates sign-tracking, but not goal-tracking (Flagel et al. 2011; Saunders and Robinson 2012; Clark et al. 2013; Saddoris et al. 2016; Fraser and Janak 2017) . More specifically, sign-but not goal-trackers show phasic fluctuations in cue-evoked DA in the NAc during PLA, and DA antagonists block sign-tracking, but not goal-tracking (Flagel et al. 2011; Clark et al. 2013) . Since CB1 receptors modulate cue-evoked phasic DA fluctuations (Cheer et al. 2004; Oleson et al. 2012) , we predict that their activation is critical for sign-tracking approach in Pavlovian lever autoshaping.
Here, we first determine whether systemic injections of the CB1 receptor inverse agonist, rimonabant, mimic the reduction in sign-tracking observed by antagonizing DA receptors (Flagel et al. 2011; Saunders and Robinson 2012; Clark et al. 2013; Chow et al. 2016; Fraser and Janak 2017) . The endogenous mechanism of eCB modulation of dopamine release occurs in the ventral tegmental area (VTA), via CB1 receptor-mediated inhibition of GABAergic neurotransmission onto DA neurons. Decreased GABA release consequently disinhibits VTA DA cell firing and increases dopamine release in striatal targets (Szabo et al. 2002; Riegel and Lupica 2004; Lupica and Riegel 2005; Covey et al. 2017) . Inverse agonists such as rimonabant counteract endogenous CB1 receptor activation and reduce striatal DA release (Cheer et al. 2004; Oleson et al. 2012) . A prior study testing the effects of systemic CB1 receptor blockade in PLA observed modest changes in lever-directed behavior only at the highest rimonabant dose tested (Thornton-Jones et al. 2005 ), but concluded that there was no effect of CB1 receptor blockade on Pavlovian approach. However, that study did not consider individual differences in approach during lever autoshaping (i.e., sign-and goal-tracking), which are associated with neurobiological variability in dopamine system involvement (Flagel et al. 2011; Saunders and Robinson 2012) . In the present study, we address this critical knowledge gap about eCB involvement in PLA by examining individual differences in approach behaviors across the entire tracking distribution to determine the role of CB1 receptor signaling in driving signtracking during Pavlovian lever autoshaping.
In Experiment 1, we trained male and female rats in PLA to determine their sign-tracking (ST), goal-tracking (GT), or intermediate (INT) group, prior to injections of rimonabant (0, 1, 3 mg/kg, i.p.) during early (5-7) and late (15-17) reinforced PLA sessions. We examined the eCB system involvement early versus late in PLA because of conflicting evidence that DA plays a time-limited role in supporting sign-tracking (Clark et al. 2013; Fraser and Janak 2017) . Here, we aim to understand the involvement of CB1 signaling after limited and extended training in PLA. To narrow in on the role of eCB in mediating the motivational significance of the lever cues used in PLA, we next examined the effect of disrupting CB1 signaling during conditioned reinforcement. Conditioned reinforcement, which is also influenced by NAc DA manipulations (Taylor and Robbins 1984; Wolterink et al. 1993) , specifically probes whether a Pavlovian cue acquires motivational significance such that it can serve as a reinforcer itself. Specifically, in Experiment 2, we over-trained male and female rats in PLA prior to examining the effect of rimonabant (0 or 1 mg/kg, i.p.) on conditioned reinforcement, in which nosepoke responding is reinforced with the previously conditioned lever cue alone. Together, the present study directly probes the extent to which CB1 signaling mediates two critical properties of incentive stimuli, their ability to attract (Exp. 1) and their ability to reinforce (Exp. 2) behavior.
Materials and methods

Animals
In Exp. 1, n = 40 (male: n = 20, female: n = 20), and Exp. 2, n = 25 (male: n = 12, female: n = 13), Long-Evans rats (Charles River Laboratories, Wilmington, MA) weighing 216-243 g at experimental onset were single-housed and maintained on a 12:12 h light-dark cycle (lights on at 6:30 a.m.). For Exp. 1 and 2, rats had ad libitum access to standard laboratory chow and tap water before food deprivation to 90% of their baseline weight, which was maintained throughout the experiment. Chow was provided after daily behavioral sessions. In both Exp. 1 and Exp. 2, one male rat was removed from each experiment due to aggressive behavior towards experimenters; thus, the final number of rats used for analysis was Exp. 1: 39 (male (n = 19) and female (n = 20), Exp. 2: n = 24 (male: n = 11, female: n = 13) All procedures were performed in accordance with the "Guide for the care and use of laboratory animals" (8th edition, 2011, US National Research Council) and were approved by the University of Maryland, School of Medicine Institutional Animal Care and Use Committee (IACUC).
Apparatus
Experiments were conducted in individual sound-isolated standard experimental chambers (25 × 27 × 30 cm; Med Associates). For Exp. 1 and 2, during Pavlovian lever autoshaping, each chamber had one red house light (6 W) located at the top of a wall that was illuminated for the duration of each session. During PLA, the opposite wall in the chamber had a recessed food cup (with photo beam detectors) located 2 cm above the floor grid. The food cup was attached to a programmed pellet dispenser that delivered 45-mg food pellets (catalog no. 1811155; Test Diet 5TUL; protein 20.6%, fat 12.7%, carbohydrate 66.7%). One retractable lever was positioned on either side of the food cup, counterbalanced, 6 cm above the floor. In Exp. 2, for conditioned reinforcement testing, the food cup was removed and the lever was positioned 6 cm above the floor in the center panel of the chamber wall. Each chamber had one red house light (6 W) located at the top of a wall that was illuminated for the duration of the conditioned reinforcement test session. One active and one inactive nosepoke port were positioned 6 cm above the floor on either side of the centrally located lever. The active nosepoke location was counterbalanced such that for half the rats, the active nosepoke was on the opposite side relative to former PLA lever location, and half the rats had active nosepoke on the same side relative to former PLA lever location. Sessions began with the illumination of a red houselight and ended 30 min later. For motor tests, the chamber walls were bare (no levers, food cups, lights, or nosepokes).
Drugs
Rimonabant (SR141716A, 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide, NIDA Drug Supply Program) was dissolved in a 1:1:18 solution of ethyl alcohol (Sigma), emulphor (Alkamuls EL-620, Solvay Chemicals, Princeton, NJ), and saline (Hospira) and sonicated for 15-30 min. Drug solutions were prepared immediately before each test session. Injections of rimonabant were administered i.p. in a volume of 1 ml/kg at doses of 0, 1, and 3 mg/kg.
Statistical analyses
Data were analyzed using SPSS statistical software (IBM) with mixed-design repeated-measures ANOVA. Significant main and interaction effects (p < 0.05) were followed by post hoc within-tracking group repeated-measures ANOVA or Bonferroni tests (reported in figure legends). For PLA training data, we used mixed repeated measures ANOVA of lever and food cup measures (contact, latency, and probability), using between-subject factors of Tracking group (ST, GT, INT) and within-subject factor of Session (1-4 or 8-14) to analyze lever-and food cup-directed behaviors. For PLA rimonabant test data, we used mixed repeated measures ANOVA including within-subject factor of drug (0, 1, 3 mg/kg) and betweensubject factors of Tracking. For conditioned reinforcement data, we used a repeated-measures ANOVA of nosepoke measures, using between-subject measures of drug (vehicle or 1 mg/kg rimonabant) and within-subject factor of response (active or inactive poke). We recognize the importance of using both males and females in our study Miller et al. 2017 ) and begin exploring the possibility of sex-differences by reporting sex effect sizes (Miller et al. 2017) . This approach allows reporting of observed differences that are independent of sample size. Sex effect sizes are expressed as Cohen's d (d = (M 1 − M 2 ) / SD pooled ), where M 1 is mean of group 1, M 2 is mean of group 2, and SD pooled = √ (s 1 2 + s 2 2 ) / 2, which is the pooled standard deviation of the two groups (Cohen 1988) . We follow general guidance for interpreting effect sizes where small effect d = 0.2, medium effect d = 0.5, and large effect d = 0.8 or larger (Cohen 1988) , and note instances that future studies should be powered to explore sex as a biological variable.
Experimental procedures
Experiment I: early and late Pavlovian lever autoshaping training and testing
Training We gave rats a single 38-min magazine training session during which one food pellet was delivered into the food cup on a variable interval (VI) 120 s schedule (60-180 s) for 20 trials. Exp. 1 timeline appears in Fig. 1a . We trained rats in four daily Pavlovian lever autoshaping (PLA) sessions, which consisted of 25 reinforced lever conditioned stimulus (CS+) presentations occurring on a VI 90 s schedule (60-120 s). Trials consisted of the insertion of a retractable lever for 10 s, after which the lever was retracted and two food pellets were delivered to the food cup regardless of whether a lever or food cup response was made.
Measurements and difference scores Measurements were collected during the 10-s CS period, and the 2.5-s post-CS reward delivery period. An automated measurement of the latency to first contact the lever and/or food cup during the cue for each trial was recorded. On trials in which a contact did not occur, a latency of 10 s was recorded. For each session, the lever or food cup probabilities were calculated by determining the number of trials that the lever or food cup response was made, divided by total number of trials in the session. We used a Pavlovian Conditioned Approach (PCA) analysis (Meyer et al. 2012 ) of day 4 performance in PLA to determine sign-, goal-, and intermediate tracking groups. The PCA score quantifies the difference between lever-directed and food cupdirected behaviors, and ranges from − 1.0 to + 1.0. An individual rat's PCA score is the average of three difference score measures (each ranging from − 1.0 to 1.0) including (1) preference score, (2) latency score, and (3) probability score. The preference score is the number of lever presses during the CS, minus the number of food cup responses during the CS, divided by the sum of these two measures. The latency score is the average latency to make a food cup response during the CS, minus the latency to lever press during the CS, divided by the duration of the CS (10 s). The probability score is the probability of lever press minus the probability of food cup response observed across the session. Sign-tracking PCA scores range from + 0.5 to + 1.0, goal-tracking PCA scores range from − 0.5 to − 1.0, and intermediate group PCA scores range from − 0.49 to + 0.49. In Exp. 1, of 39 rats, 19 were ST (10 male, 9 female), 9 were GT (4 male, 5 female), and 11 were INT (5 male, 6 female). After PLA training (sessions 1-4) and testing (sessions 5-7 described below), we retrained rats in seven drug-free PLA sessions (8-14) followed by the late rimonabant testing (sessions 15-17; Fig. 1 ). To explore possible sex differences in response to rimonabant, we calculated behavioral difference scores and examined sex effect sizes between males and females under drug and vehicle conditions. For each rat, we calculated difference scores for each rimonabant dose that compared contact behaviors under drug and vehicle conditions. The lever and food cup difference scores were equal to the number of contacts after rimonabant injections minus number of contacts after vehicle injections (1 mg/kg − vehicle) and (3 mg/kg − vehicle).
Testing We habituated rats to i.p. vehicle injections before the start of the fourth PLA session. For early PLA testing (sessions 5-7), we gave each rat an injection of rimonabant (0, 1, Training We trained a separate cohort of n = 24 (male n = 11, female n = 13) rats in 22 drug-free, PLA sessions as described in training section of Exp. 1 above, prior to conditioned reinforcement testing.
Conditioned reinforcement testing We gave rats a 30-min conditioned reinforcement test 1 day after the last PLA session. In this task, rats learn to make an instrumental nosepoke response to gain brief access to the Pavlovian lever cue alone. Importantly, no food reinforcers are delivered during conditioned reinforcement. A single poke in the active port resulted in a 2-s extension and retraction of the lever cue. A poke in the inactive port had no programmed consequences. The number of active pokes and inactive pokes was recorded. We gave half of the rats i.p. vehicle injections and the other half i.p. rimonabant (1 mg/kg) injections. Immediately after injections, we placed rats in their homecage for 30 min, then to behavioral chambers for testing. After a 10-min acclimation period in the behavioral chambers, we started the conditioned reinforcement test session. We counterbalanced tracking group, sex, and active nosepoke location between treatment groups.
Measurements and difference scores Measurements and analyses for PLA were collected and analyzed as described above. For conditioned reinforcement testing, measurements were collected continuously through the entire 30-min test session. Automated measurements included the total number of active and inactive nosepoke beambreaks. To examine the timecourse of nosepoke responding during conditioned reinforcement, video was recorded for 16 (male = 8; four veh, four rimonabant, female = 8; three vehicle, four rimonabant) out of the 24 rats. To explore possible sex differences in conditioned reinforcement and response to rimonabant, we calculated nosepoke discrimination scores and examined sex effect sizes between males and females under drug and vehicle conditions. For each rat, we calculated discrimination scores that were equal to active nosepokes minus inactive nosepokes. For time-course data, we scored videos counting the number of active and inactive nosepokes per minute and summing in 5-min bins. Total active and inactive pokes scored from the videos correlated with the automated nosepoke totals collected by the computer (r 2 = 0.98 vehicle group, r 2 = 0.91 rimonabant group).
Motor and consumption testing We maintained rats from Exp. 2 at 90% food deprivation and gave them a 30-min motor activity test followed immediately by a 30-min pellet consumption test. We gave n = 8 rats per group i.p. vehicle, 1 or 3 mg/kg rimonabant injections. Immediately after injections, we placed rats in their homecage for 30 min, then to empty behavioral chambers where we video recorded motor activity for 30 min (EthoVision XT v9; Noldus, Wageningen, the Netherlands). To calculate % time motile in chamber, we divided the cumulative time motile by 30 min. Time motile is defined as time spent walking, grooming, or rearing. Immediately after the session, we placed rats in the homecage with 50 pellets (weighing a total of 2.25 g) in a pre-habituated white, ceramic ramekin dish (diameter = 10.5 cm, height = 4.2 cm) for 30 min. Pellets (45 mg pellets; catalog no. 1811155; Test Diet 5TUL; protein 20.6%, fat 12.7%, carbohydrate 66.7%) were identical to those used in autoshaping. We quantified consumption by subtracting the number of pellets remaining after 30 min from 50 pellets given at the start of the test.
Results
Experiment 1: effect of rimonabant on approach in Pavlovian lever autoshaping
In Experiment 1, we examine the role of CB1 signaling in mediating sign-tracking. Here, we sought to understand the involvement of CB1 signaling after limited and extended conditioning in PLA. Exp. 1 timeline appears in Fig. 1a . The tracking group was determined from performance in the fourth PLA training session using each rats' Pavlovian conditioned approach (PCA) score (Fig. 1b) , which are a comprehensive measure of individual differences in PLA that account for contact, latency, and probability differences between leverand food cup-directed behaviors (Meyer et al. 2012) . Table 1 summarizes main effects and interactions from analyses of lever and food cup contact (Fig. 1c, d, left) , latency ( Fig. S1B-C left) , and probability data ( Fig. S1D-E left) from the first four training sessions. Additionally, there were no differences in acquisition of the preferred conditioned response (lever contact for ST and food cup contact for GT) between sign-and goal-trackers (supplemental information, Fig. S1A ). Looking within tracking groups, there were no notable sex effect sizes during the fourth PLA training session.
In the next three consecutive sessions, we gave rats rimonabant (0, 1, or 3 mg/kg, counterbalanced) before each PLA session. Consistent with our prediction that rimonabant would suppress sign-tracking (Fig. 1c right) , in our analysis of lever contacts, we observed main effects of Drug (F(2,72) = 5.035, p = 0.009) and Tracking (F(2,36) = 12.88, p = 0.001) but surprisingly no Drug × Tracking interaction, suggesting that rimonabant similarly reduced the number of lever contacts across all rats. Exploring Drug × Tracking interactions (supplementary information) for other lever measurements revealed that rimonabant dose-dependently increased lever latency in ST, but not GT or INT (supplementary information, Fig. S1B right) and decreased probability of lever contact exclusively in ST rats (supplementary information, Fig. S1C  right) . Thus, only in ST rats were all three measures of signtracking (contact, latency, and probability) affected by rimonabant treatment. We observed a small sex effect size for the effect of rimonabant on lever contact difference scores at 1 mg/kg that was amplified when looking specifically in ST rats (supplementary information Surprisingly, rimonabant also affected food cup contacts early in lever autoshaping (Fig. 1d right) . We observed main effects of Drug (F(2,72) = 17.94, p < 0.001) and Tracking (F(2,36) = 32.67, p < 0.001) and a Drug × Tracking interaction (F(4,72) = 8.63, p < 0.001), suggesting that rimonabant differentially affected food cup behavior between groups. Separated by tracking, there was a main effect of Drug for GT and INT, but not ST (GT: F(2,16) = 6.89, p = 0.007; INT: F(2,20) = 5.91, p = 0.01). Rimonabant dosedependently increased food cup latency in GT, but not ST or INT (supplementary information, Fig. S1C right) . The observation that rimonabant treatment did not slow either lever or food cup responding in INT rats that perform both responses suggests that rimonabant did not have general motor suppressive effects that could impair responding at these stimulus locations. Consistent with reduced number of food cup contacts, there was also a reduced probability of food cup contact in GT and was marginally significant for INT (supplementary information, Fig. S1E right) . There were no notable sex effect sizes that would indicate potential sex differences in sensitivity of food cup approach to rimonabant.
To test the possibility that rimonabant affected reward collection or consumption, we analyzed food cup contacts during the 2.5-s period after lever retraction when pellets were delivered. There were no significant main effects of Drug, Tracking, nor Drug × Tracking interactions (Fig. S1G) . Rats consumed all of their pellets during PLA test sessions (data not shown). Altogether, the effects of rimonabant were specific to approach behaviors during the Pavlovian cue period and did not affect reward collection or consumption once pellets were delivered.
We examined the effect of rimonabant on the population distribution of PCA scores during early tests (Fig. 1e) . We performed Wilcoxon signed-rank tests to compare PCA scores under vehicle versus rimonabant conditions (Fig. 1e) . PCA scores for the ST population were significantly left-shifted by 3 mg/kg rimonabant treatment (Wilcoxon signed rank: Z = − 2.98, p < 0.01), but there was no shift for GT (Fig. 1e) or INT (data not shown). Notably, there may have been limited power to detect PCA shifts in the considerably smaller GT and INT groups, yet even when combined, there was no evidence for a positive shift in the GT/INT population. Altogether, analyses of individual data and population level analyses of comprehensive PCA scores reveal that rimonabant treatment significantly reduces sign-tracking early in Pavlovian lever autoshaping.
Next, we trained rats in seven additional PLA sessions. Notably, for PCA scores during extended training (Fig. 2a  left) , there were main effects of Session and Tracking and a Session × Tracking interaction (Table 2) . Separated by tracking group, there were main effects of session for all three groups, with previously identified GT rats showing the most pronounced shift in PCA scores during extended training (GT: F(6,48) = 8.77, p < 0.001; INT: F(6,60) = 5.49, p < 0.001; ST: F(6,108) = 2.63, p = 0.02). The population distribution of PCA scores on day 14 differed from day 4 PCA scores (supplementary information; Fig. S2D ). Rats' lever and food cup contact data are shown in Fig. 2b , c left. There were main effects of Session and Tracking and Session × Tracking interactions for nearly all lever and food cup contact measures, which are reported in Table 2 . We observed large sex effect sizes for lever-directed behavior that emerged during retraining phase of PLA, such that on the last 3 days of training, females made fewer lever contacts (d = 1.03) at a slower Fig. S2A-C) . Next, we examined the effect of rimonabant on leverdirected behavior after extended Pavlovian training. For lever contact data (Fig. 2b right) , there were main effects of Drug (F(2,72) = 5.68, p = 0.005) but no main effect of Tracking nor any interactions. This suggests an overall drug effect that reduced lever contacts in all tracking groups. Lever latency and probability data are reported in Fig. S2B -C right and supplementary information. The sex differences observed during training were maintained in testing, in that females made fewer lever contacts than males (Fig. S2A) . We observed a small sex effect size for the effect of rimonabant on lever contact difference scores at 3 mg/kg (supplementary information; Fig. S2C left; Cohen's d = 0.244) that was similar when looking only at behavior of ST rats (Fig. S2C right; Cohen's d = 0.210). For food cup contacts (Fig. 2c) , there was a main effect of Tracking (F(2,36) = 14.90, p < 0.001) but no main effect or interactions with Drug. Similar to earlier phases of rimonabant testing, there were no effects of rimonabant on food pellet collection or consumption during the post-cue period (Fig. S2F) . Finally, we performed a single Wilcoxon signed-rank test of the PCA scores of the entire population to compare PCA scores with vehicle versus 3 mg/kg rimonabant (Fig. 2d ). There was a significant negative shift of PCA scores with 3 mg/kg compared to vehicle conditions (Z = − 2.04, p < 0.05) reconfirming that predominantly lever-directed behavior in late Pavlovian conditioning is reduced by rimonabant.
Experiment 2: effect of rimonabant on conditioned reinforcement
In Experiment 1, rimonabant's attenuating effects on leverdirected behaviors were consistent after both limited and extended training in PLA. This suggests that CB1 signaling mediates the "attracting" properties of lever cues, which are postulated to accrue reinforcing value through pairings with the reward. However, from testing rimonabant's effects in reinforced lever autoshaping sessions, it is unclear whether CB1 signaling is critical for representing the reinforcing value of the lever cue itself. In Experiment 2, we examined the effect of rimonabant on conditioned reinforcement in rats with extended training in PLA. Conditioned reinforcement is a procedure that specifically probes whether the Pavlovian lever cue can serve as a reinforcer itself. Exp. 2 timeline appears in Fig. 3a . We first gave rats extended training in PLA. Similar to Exp. 1, we observed that rats with GT and INT PCA scores early in lever autoshaping shifted towards ST PCA scores with extended training (Fig. 3b) . Importantly, on the last 3 days of conditioning prior to the conditioned reinforcement test, all rats engaged in leverdirected behavior prior to conditioned reinforcement (Fig. S3A right) and there were no notable sex effect sizes across all rats (but see supplementary information for large sex effect sizes in ST rats).
Behavior during the conditioned reinforcement test is shown in Fig. 3c . During conditioned reinforcement, we observed a main effect of Response (F(1,20) = 100.069, p < .0001), indicating that rats discriminated between active and inactive ports. Thus, the Pavlovian lever cue served as a robust conditioned reinforcer after Pavlovian lever autoshaping. We did not observe any notable sex effect sizes under vehicle conditions, suggesting that males and females showed similar discrimination of the active and inactive nosepokes (Fig. S3B-C left) . During conditioned reinforcement, we observed a main effect of Drug (F(1,22) = 6.808, p = 0.016) and a Response × Drug interaction (F(1,22) = 8.080, p = 0.009) demonstrating that rimonabant reduces active nosepoke responding that resulted in the lever cue insertion. The time course of conditioned reinforcement is shown in Fig. 3d 2 timeline. We trained rats in 22 daily PLA sessions. We tested rats with systemic injection of rimonabant (0 and 1 mg/kg) during a conditioned reinforcement test. We gave rats rimonabant (0, 1, or 3 mg/kg) before a motor activity and satiety test. b Rats with GT and INT PCA scores early in lever autoshaping shifted towards ST PCA scores with extended PLA training. c During conditioned reinforcement, rats discriminated between active and inactive ports, suggesting the inserted lever cue served as a robust conditioned reinforcer. Rimonabant decreased the number of active, but not inactive pokes suggesting that rimonabant attenuates the conditioned reinforcing properties of the Pavlovian lever cue. d Time course of nosepokes (binned in 5-min blocks) during conditioned reinforcement test. Rimonabant blunted the number of active nosepokes, while extinction curves were unaffected. *Significant main effect of Session, Response, or Drug; #significant Session × Tracking, Drug × Response interaction 70) = 29.523, p < 0.001), but the Drug × Block interaction was not significant. This suggests that rimonabant blunted nosepoke responding for the lever cue presentation, while the rate of extinction was similar in both groups. That is, when CB1 signaling is disrupted, the lever cue is a less effective conditioned reinforcer. We observed a very large sex effect size for rimonabant's attenuation of nosepoking, such that conditioned reinforcement in females may be more sensitive to rimonabant treatment compared to males ( Fig. S3C; Cohen's d = 1.057). Thus, future studies examining CB1-mediated effects on conditioned reinforcement should be powered to examine sex as a biological factor. To determine whether rimonabant had non-specific effects on motor activity, we measured rats' percent time motile in the experimental chamber after vehicle, 1 or 3 mg/kg rimonabant ( Fig. S4A; supplementary information) . There was no evidence for sedative effects of rimonabant. To determine whether rimonabant had sating effects, we measured pellet consumption in these three dose conditions. Rats in all three groups consumed all of their pellets (Fig. S4B ). These two results suggest that rimonabant (1 mg/kg or 3 mg/kg) did not induce satiety or sedation that could account for our observations in Exp. 1 or 2. Thus, rimonabant specifically attenuates the motivational properties of the lever cue, both in the presence (Exp. 1) and absence (Exp. 2) of primary reinforcement.
Discussion
Here, we first examined whether disrupting CB1 receptor signaling in Pavlovian lever autoshaping would reduce signtracking behavior in Pavlovian lever autoshaping. We found that systemic rimonabant injections dose-dependently attenuated the cue-driven lever approach in sign-trackers early in lever autoshaping. With extended training, many previously goal-tracking and intermediate rats shifted towards leverdirected behaviors, which remained dose-dependently sensitive to the effects of rimonabant. A separate cohort of rats also showed an extended training-dependent shift towards leverdirected behavior, in the absence of any rimonabant treatment during training. During conditioned reinforcement tests, rats receiving vehicle injections acquired a novel instrumental nosepoke response for the lever cue alone, but rats given rimonabant failed to acquire this conditioned response. Together, these results suggest that CB1 signaling is critical for mediating the attracting and conditioned reinforcing properties of Pavlovian lever cues.
Sign-tracking to lever cues has been posited to reflect an incentive motivational process in which the appetitive motivational properties of the reward are transferred to the conditioned lever cue, such that the lever cue attracts, invigorates, and reinforces behavior (Tomie 1996; Flagel et al. 2009; Robinson and Flagel 2009; Beckmann and Chow 2015) . While CB1 signaling is involved in the attracting (Exp. 1) and reinforcing properties (Exp. 2) of lever cues, we also find that CB1 signaling supports late lever-directed behaviors regardless of rats' initial tracking group. Rimonabant's attenuation of lever-directed behavior late in training when signtracking has been shown to be less dependent on dopaminergic activity might suggest a non-specific effect of rimonabant (Clark et al. 2013 ). However, recent work has shown sustained dopamine dependency for lever-directed behavior after extended training (Fraser and Janak 2017) . Rimonabant also attenuated cue-evoked food cup approach early, but not late, in conditioning. Importantly, rimonabant did not affect pellet retrieval during PLA (Exp. 1) or ad libitum pellet consumption (Exp. 2), demonstrating that CB1 signaling is uniquely involved early in learning to drive cue-evoked food cup and lever-directed approach. Thus, CB1-dependent early food cup approach may in part reflect a cue-specific, but response-independent, motivational process common to both sign-and goal-trackers. Consistent with this interpretation, only GT and ST rats showed dose-dependent reductions in all three measures of approach behavior (contact, latency, and probability), while INT rats did not. In Exp. 1, the latency to approach the lever and food cup in INT rats did not change significantly with rimonabant treatment, and in Exp. 2, there were no motor suppressive effects of rimonabant, limiting the possibility that rimonabant had sedative effects. Notably, by examining multiple measures of approach behaviors across the entire continuum of PCA scores, we have elucidated a critical role of CB1 signaling in supporting both sign-and goal-tracking early and learning that may have previously been overlooked (Thornton-Jones et al. 2005) . Whether CB1-mediated approach in sign-and goal-trackers is driven by common or divergent brain systems remains an open question, as does the specific brain region mediating CB1-signaling of incentive and reinforcing properties of Pavlovian lever cues.
Notably, the eCB system is involved in the regulation of food intake as well as the sensory and hedonic processing of food (Mahler et al. 2007; Soria-Gomez et al. 2014; Lau et al. 2017) . CB1 agonists generally induce hyperphagia and locally modulate neurotransmission in the VTA and NAc to influence dopamine release in response to the consumption of palatable foods (Mahler et al. 2007 ). Conversely, blocking eCB signaling has anorectic effects and decreases ad libitum feeding behavior (Tallett et al. 2007 ). In the present study, we observed that rats consumed all of the pellets delivered during Pavlovian lever autoshaping (Exp. 1) and during an ad libitum homecage pellet consumption test (Exp. 2). The food deprivation conditions used in our study enhance motivation for food, which likely masked any anorectic effects of rimonabant, particularly in PLA during which only 50 pellets were delivered. Together, these results limit the possibility that rimonabant had sating effects that lead to the blunted motivation to engage in the PLA task. In further support ofimplicate other putative CB1-mediated targets. For example, cholinergic modulation of striatal dopamine release also mediates the expression of cue-motivated behaviors (Collins et al. 2016) . Endocannabinoid regulation of striatal glutamate release drives striatal cholinergic interneurons, which in turn drive impulse-independent DA release (Exley et al. 2008; Threlfell et al. 2012; Mateo et al. 2017) . Others have shown that endocannabinoid attenuation of cortical glutamate release in the dorsal medial striatum mediates the transition between goal-directed and habitual behaviors, which are defined by their sensitivity to changes in outcome value (Gremel et al. 2016) . Given the differential sensitivity of sign-and goal-trackers to changes in outcome value (Anselme et al. 2013; Ahrens et al. 2015; Morrison et al. 2015; Nasser et al. 2015; Smedley and Smith 2018) , this may be another viable target for exploring the contributions of CB1 signaling on sign-and goal-tracking behaviors. Notably, the motivational properties of natural rewards depend on endocannabinoid and opiate system interactions within mesocorticolimbic circuitry. CB1-mediated mu-and/or kappa-opiate receptor-dependent motivational effects may contribute to the behavioral effects we observed in the present study (Solinas and Goldberg 2005; Ahmad et al. 2013; . Endocannabinoid signaling in the amygdala as also been implicated in relevant behaviors including positive and negative reinforcement, aversive learning, and affective memory processes (Campolongo et al. 2009; Tan et al. 2011; Trezza et al. 2012; . The current study highlights the important role CB1 signaling plays in representing the attracting and reinforcing properties of Pavlovian lever cues, and serves as a foundation for exploring a variety of CB1 mechanisms mediating neurotransmission in VTA, NAc, dorsal striatum, and beyond.
Together, our results suggest that CB1 signaling supports sign-tracking, through the expression of the incentive motivational and conditioned reinforcing properties of Pavlovian lever cues. Our comprehensive analyses of individual differences across the entire continuum of tracking behaviors have elucidated a critical role of CB1 signaling in supporting Pavlovian approach that was previously overlooked. Future studies targeting CB1 signaling in specific brain circuitry will determine whether these individual differences in approach and conditioned reinforcement are neurobiologically dissociable. 
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